Use of genetically manipulated strains of Clostridium perfringens reveals that both alpha-toxin and theta-toxin are required for vascular leukostasis to occur in experimental gas gangrene

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4902-4907

  Ellemor, Darren M ^a,c   Baird, Rebecca N ^a   Awad, Milena M ^b   Boyd, Richard L ^a   Rood, Julian I ^b   Emmins, John J ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM PERFRINGENS; GAS GANGRENE; GENETIC MANIPULATION; LEUKOCYTE AGGREGATION; LEUKOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TISSUE NECROSIS; TOXIN SYNTHESIS;

EID: 0032785378     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4902-4907.1999     Document Type: Article

References (14)

1. Awad, M., A. Bryant, D. Stevens, and J. Rood. 1995. Virulence studies on chromosomal α-toxin and θ-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α-toxin in Clostridium perfringens-mediated gas gangrene. Mol. Microbiol. 15:191-202.
2. Awad, M., and J. Rood. 1997. Isolation of α-toxin, θ-toxin and κ-toxin mutants of Clostridium perfringens by Tn916 mutagenesis. Microb. Pathog. 22:275-284.
3. Bannam, T., and J. Rood. 1992. Clostridium perfringens-Escherichia coli shuttle vectors that carry single antibiotic resistance determinants. Plasmid 229: 233-235.
4. Bryant, A., R. Bergstrom, G. Zimmerman, J. Salyer, H. Hill, R. Tweten, H. Sato, and D. Stevens. 1993. Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol. Med. Microbiol. 7:321-336.
5. Bryant, A., and D. Stevens. 1996. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect. Immun. 64:358-362.
6. Bunting, M., D. Lorant, A. Bryant, G. Zimmerman, T. McIntyre, D. Stevens, and S. Prescott. 1997. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J. Clin. Investig. 190:565-574.
7. McDonel, J. 1986. Toxins of Clostridium perfringens type A, B, C, D, and E, p. 477. In F. Dorner and J. Drews (ed.), Pharmacology of bacterial toxins. Pergamon Press, Oxford, United Kingdom.
8. McNee, J., and J. Dunn. 1917. The method of spread of gas gangrene into living muscle. BMJ 1:727-729.
9. Onderdonk, A. B., and S. D. Allen. 1995. Clostridium, p. 574-586. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
10. Robb-Smith, A. 1945. Tissue changes induced by Cl. welchii type A filtrates. Lancet 2:362-368.
11. Rood, J., and S. Cole. 1991. Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol. Rev. 55:621-648.
12. Sloan, J., T. Warner, P. Scott, T. Bannam, D. Berryman, and J. Rood. 1992. Construction of a sequenced Clostridium perfingens-Escherichia coli shuttle plasmid. Plasmid 27:207-219.
13. Wells, C., and T. Wilkins. 1991. Clostridia: spore-forming anaerobic bacilli, p. 279-296. In S. Brown (ed.), Medical microbiology, 3rd ed. Churchill Livingstone, New York, N.Y.
14. Whatley, R., P. Nelson, G. Zimmerman, D. Stevens, C. Parker, T. McIntyre, and S. Prescott. 1989. The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J. Biol. Chem. 264:6325-6333.